Alxerion Biotech is proud to announce its participation in the 2018 edition of the BIO International Convention in Boston, MA, USA, from June 4-7.
Scientific Co-Founder and CEO Prof. Dr. Javier Pedreño will take part in the Convention as Speaker, introducing our innovative exosome-based drug delivery and drug development programs on Monday, June 4th, at 4:15pm in Theater 3 Level 0.
For more information regarding the presentation please visit https://mybio.org/event/member/487153
In addition, a press conference will be held Tuesday, June 5th, at 10AM in Room 153B. In this, Prof. Dr. Mercedes Balcells and Prof. Dr. Javier Pedreño will announce important breakthroughs in exosome-based treatments, with COO Steven Hite also on hand for discussions on partnering opportunities.
For more information regarding the press conference please visit https://mybio.org/event/member/488367
About 2018 Bio International Convention:
BIO International Convention is back in Boston, June 4-7, to celebrate history-making innovation. This is the only event where you can access the global biotech and pharma community via Partnering, attend 150 education sessions and network with 16,000+ attendees from 74 countries. Discover the next generation of cutting-edge products, therapies, and cures at events all week long at BIO 2018. Learn more at convention.bio.org